; Review of the Evidence for Treatment of Children with Autism with Selective Serotonin Reuptake Inhibitors
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Review of the Evidence for Treatment of Children with Autism with Selective Serotonin Reuptake Inhibitors

VIEWS: 1 PAGES: 9

PURPOSE: To review the potential role of serotonin dysregulation in autism and the efficacy of selective serotonin reuptake inhibitors (SSRIs) in treating core deficits and associated symptoms of autism in children. The literature was searched for reports of SSRI use in children with autism. Data are presented from prospective clinical trials that evaluated treatment outcomes. CONCLUSIONS: Some SSRIs show moderate success in managing specific behaviors. Only fluoxetine shows evidence of decreasing global autism severity. PRACTICE IMPLICATION: Definitive conclusions concerning selection criteria, dosage, safety, and efficacy cannot be drawn given the current state of evidence.

More Info
  • pg 1
									Review of the Evidence for Treatment of Children with Autism with Selective S...
Lis West; Susan H Brunssen; Julee Waldrop
Jou
								
To top
;